(+)-4,7-Dichloro-3-(2-(4-cyclopropylphenyl)-2-oxoethyl)-3-hydroxyindolin-2-one

Catalog No. :
ACUXMO151
CAS No. :
1903783-77-6
Molecular Formula :
C19H15Cl2NO3
Molecular Weight :
376.24

IUPAC Name:4,7-dichloro-3-(2-(4-cyclopropylphenyl)-2-oxoethyl)-3-hydroxyindolin-2-one

(+)-4,7-Dichloro-3-(2-(4-cyclopropylphenyl)-2-oxoethyl)-3-hydroxyindolin-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$307.00Login to see priceInquiryInquiry
5mg98%$675.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(+)-4,7-Dichloro-3-(2-(4-cyclopropylphenyl)-2-oxoethyl)-3-hydroxyindolin-2-one
IUPAC Name4,7-dichloro-3-(2-(4-cyclopropylphenyl)-2-oxoethyl)-3-hydroxyindolin-2-one
Molecular FormulaC19H15Cl2NO3
Molecular Weight376.24
SMILESO=C1NC2=C(C(Cl)=CC=C2Cl)C1(CC(C3=CC=C(C4CC4)C=C3)=O)O
InChI KeyZWHNLSHDLKIXOG-UHFFFAOYSA-N
Synonym(+)-TK216
CAS No.1903783-77-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACUXMO151 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTXAI971 route compound structure diagram
    ACTXAI9716921-45-5 In Stock
  2. Plus
  3. ACBPUE675 route compound structure diagram
    ACBPUE67518711-13-2 In Stock
  4. Then
  5. ACUXMO151 route product structure diagram
    ACUXMO1511903783-77-6
Inquiry

2. ACUXMO151 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTXAI971 route compound structure diagram
    ACTXAI9716921-45-5 In Stock
  2. Plus
  3. ACBPUE675 route compound structure diagram
    ACBPUE67518711-13-2 In Stock
  4. Then
  5. ACUXMO151 route product structure diagram
    ACUXMO1511903783-77-6
Inquiry

Comments (0)